Pivagabine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePivagabine

Drug Alias NameCXB-722

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCorticotropin-releasing factor receptor 2 antagonistsCorticotropin-releasing factor receptor 1 antagonists

TargetsCorticotropin-releasing factor receptor 1Corticotropin-releasing factor receptor 2

Therapy Area/IndicationsAnxietyStress, PsychologicalDepression

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCenerx

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsAnxietyStress, PsychologicalDepression

ATC CodeN06AX15